Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients
- PMID: 19465588
- DOI: 10.1093/rheumatology/kep082
Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients
Abstract
Objective: Plasma concentration of asymmetric dimethylarginine (ADMA), a major endogenous inhibitor of nitric oxide synthase, is considered a novel risk factor for endothelial dysfunction associated with enhanced atherosclerosis. Coronary microcirculation abnormalities have been demonstrated in patients with early rheumatoid arthritis (ERA) without any signs or symptoms of coronary artery disease (CAD). The aim of the study was to compare the ERA and control groups with ADMA, intima-media thickness (IMT) and coronary flow reserve (CFR) levels. It assessed whether ERA patients have more cardiovascular risk (endothelial dysfunction and coronary microvascular abnormalities), and evaluated whether any difference in IMT/CFR between ERA and controls can be explained by any difference in ADMA levels between the groups.
Methods: The study involved 25 ERA patients (female/male 21/4; mean age 52.04 +/- 14.05 years; disease duration <or=12 months) and 25 healthy volunteers with no history or current signs of CAD or other traditional risk factors. Dipyridamole trans-thoracic stress echocardiography was preformed to evaluate CFR, and carotid ultrasound to measure the IMT of the common carotid arteries. Blood samples were obtained in order to assess ADMA levels before the patients had received any biological or non-biological DMARDs, or steroid therapy.
Results: CFR was significantly reduced in the ERA patients (2.5 +/- 0.5 vs 3.5 +/- 0.8; P <0.01). In particular, 6/25 (24%) had a CFR of <2 consistent with potentially dangerous coronary flow impairment. Common carotid IMT was significantly greater in the ERA patients, although still within the normal range (0.68 +/- 0.1 vs 0.56 +/- 0.11 mm; P <0.01). There was a significant correlation between CFR and plasma ADMA levels in the ERA population (r = -0.53; P <0.01). IMT was negatively associated with CFR (P <0.05).
Conclusions: Plasma ADMA levels were significantly higher in the ERA patients. A statistically significant negative effect of ADMA levels on CFR value was observed. The effect of ADMA levels on IMT is not significant.
Similar articles
-
Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis.J Rheumatol. 2011 Aug;38(8):1661-4. doi: 10.3899/jrheum.100893. Epub 2011 Jun 1. J Rheumatol. 2011. PMID: 21632673
-
Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.Cardiovasc Ther. 2010 Oct;28(5):e53-64. doi: 10.1111/j.1755-5922.2009.00119.x. Cardiovasc Ther. 2010. PMID: 20337633
-
Carotid intima-media thickness in patients with cardiac syndrome X and its association with high circulating levels of asymmetric dimethylarginine.Atherosclerosis. 2009 Jun;204(2):e82-5. doi: 10.1016/j.atherosclerosis.2008.09.029. Epub 2008 Oct 8. Atherosclerosis. 2009. PMID: 19010468
-
Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: a systematic review and meta-analysis of case-control studies.Clin Rheumatol. 2020 Jan;39(1):127-134. doi: 10.1007/s10067-019-04713-z. Epub 2019 Aug 3. Clin Rheumatol. 2020. PMID: 31376089
-
Cardiovascular involvement in psoriatic arthritis.Reumatismo. 2011 Nov 9;63(3):148-54. doi: 10.4081/reumatismo.2011.148. Reumatismo. 2011. PMID: 22257915 Review.
Cited by
-
Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases.Front Med (Lausanne). 2018 Feb 14;5:26. doi: 10.3389/fmed.2018.00026. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29497612 Free PMC article. Review.
-
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.BMJ. 2018 Apr 23;361:k1036. doi: 10.1136/bmj.k1036. BMJ. 2018. PMID: 29685876 Free PMC article. Review.
-
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA).Toxins (Basel). 2017 Mar 6;9(3):92. doi: 10.3390/toxins9030092. Toxins (Basel). 2017. PMID: 28272322 Free PMC article. Review.
-
Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?Healthcare (Basel). 2016 Jul 8;4(3):40. doi: 10.3390/healthcare4030040. Healthcare (Basel). 2016. PMID: 27417628 Free PMC article. Review.
-
Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.Int J Mol Sci. 2012 Sep 26;13(10):12315-35. doi: 10.3390/ijms131012315. Int J Mol Sci. 2012. PMID: 23202900 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous